Absci Corporation - Common Stock (ABSI) stock analysis
ABSI · Absci Corporation - Common Stock
Latest recorded price: USD 7.47
Sector and industry: Healthcare · Biotechnology
Fiscal 2024 figures: revenue growth -1.8%, free cash flow margin -1,605.8%. The model flags 2 risk signals for this company (2 high severity).
Similar companies in Healthcare
- Acadia Pharmaceuticals Inc. (ACAD)
- ADMA Biologics, Inc. (ADMA)
- Agios Pharmaceuticals, Inc. (AGIO)
- Alnylam Pharmaceuticals, Inc. - Common Stock (ALNY)
- AnaptysBio, Inc. - Common Stock (ANAB)
- Arrowhead Pharmaceuticals, Inc. - Common Stock (ARWR)
- Aurinia Pharmaceuticals Inc - Common Shares (AUPH)
- Axsome Therapeutics, Inc. - Common Stock (AXSM)